Literature DB >> 12635144

The haematopoietic specific signal transducer Vav1 is expressed in a subset of human neuroblastomas.

Idit Hornstein1, Eli Pikarsky, Maya Groysman, Gail Amir, Nili Peylan-Ramu, Shulamit Katzav.   

Abstract

Vav1 is a signal transducer protein expressed exclusively in the haematopoietic system, where it plays a pivotal role in growth factor-induced differentiation and proliferation. Vav1 couples tyrosine kinase signals with the activation of the Rho/Rac GTPases, leading to cell differentiation and/or proliferation. Vav1 was originally detected as an oncogene, but its involvement in human malignancies has not been reported thus far. We report here that Vav1 is expressed in a neuroblastoma cell line, SK-N-MC. Molecular analysis indicated that there are no gross rearrangements or mutations in the Vav1 gene in SK-N-MC cells. Vav1 protein from SK-N-MC cells was similar to wild-type Vav1 in apparent molecular weight, phosphorylation state, and ability to associate with active EGFR. We also analysed the expression of Vav1 in 42 specimens of human neuroblastoma. Vav1 was expressed in the majority of these tumours. Our results suggest that Vav1 may play a role in the neoplastic process in a subset of neuroblastomas. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12635144     DOI: 10.1002/path.1314

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  30 in total

1.  Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.

Authors:  Galit Lazer; Liron Pe'er; Marganit Farago; Kazuya Machida; Bruce J Mayer; Shulamit Katzav
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion.

Authors:  Rubén A Bartolomé; Isabel Molina-Ortiz; Rafael Samaniego; Paloma Sánchez-Mateos; Xosé R Bustelo; Joaquin Teixidó
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

Review 3.  Rho GTPases: functions and association with cancer.

Authors:  Saskia I J Ellenbroek; John G Collard
Journal:  Clin Exp Metastasis       Date:  2007-11-14       Impact factor: 5.150

4.  Vav1 in hematologic neoplasms, a mini review.

Authors:  Matthew J Oberley; Deng-Shun Wang; David T Yang
Journal:  Am J Blood Res       Date:  2012-01-01

5.  Clinical significance and prognostic value of Vav1 expression in Non-small cell lung cancer.

Authors:  Yao Qi; Fan-Ming Kong; Qi Deng; Jing-Yi Li; Rui Cui; Ye-Di Pu; Qiong-Li Zhai; Ying-Jie Jia; Yu-Ming Li
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

6.  Total alkaloids of Corydalis saxicola bunting inhibits migration of A549 cells by suppressing Cdc42 or Vav1.

Authors:  Mimi Li; Jiying Wang; Biwen Mo; Jinrong Zeng; Dong Yao; Feng Chen; Ming Jiang; Lizong Rao; Yinjun Du
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

7.  The distinct role of guanine nucleotide exchange factor Vav1 in Bcl-2 transcription and apoptosis inhibition in Jurkat leukemia T cells.

Authors:  Jie Yin; Ya-juan Wan; Shi-yang Li; Ming-juan Du; Cui-zhu Zhang; Xing-long Zhou; You-jia Cao
Journal:  Acta Pharmacol Sin       Date:  2010-12-13       Impact factor: 6.150

Review 8.  Approaches of targeting Rho GTPases in cancer drug discovery.

Authors:  Yuan Lin; Yi Zheng
Journal:  Expert Opin Drug Discov       Date:  2015-06-18       Impact factor: 6.098

9.  Dynamin 2 potentiates invasive migration of pancreatic tumor cells through stabilization of the Rac1 GEF Vav1.

Authors:  Gina L Razidlo; Yu Wang; Jing Chen; Eugene W Krueger; Daniel D Billadeau; Mark A McNiven
Journal:  Dev Cell       Date:  2013-03-25       Impact factor: 12.270

Review 10.  Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease.

Authors:  D R Cook; K L Rossman; C J Der
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.